A record of what Kotak Institutional Equities Analysis said publicly, with the source. Not advice.
“Initiated coverage on Dr Agarwal's Health Care with an 'Add' rating and a target price of ₹425, implying a 7.6% potential upside from its Tuesday closing price. The brokerage expects strong earnings growth and improving return ratios, forecasting 23% EBITDA and 27% EPS CAGR over FY2024–28, driven by organic expansion and operational ramp-up. Risks include high South India revenue concentration and integration issues.”
Kotak Institutional Equities Analysis’s track record (trackable calls only): 40 graded calls · 95% CI 29–58%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹425, as stated.
Window: 12 months, the default when no time frame is stated.
Window still open: no verdict until a close reaches a level or the window ends.
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.